Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Myriad

Myriad is a personalized medicine company that discovers and commercializes molecular diagnostic tests and equipment for inherited diseases. Read more

1,026 Followers on Owler
1,026 Followers on Owler
1,026 Followers on Owler
1,026 Followers on Owler

Myriad

Myriad is a personalized medicine company that discovers and commercializes molecular diagnostic tests and equipment for inherited diseases. Read more

Paul J. Diaz's photo - President & CEO of Myriad

President & CEO

Paul J. Diaz

CEO Approval Rating

86/100

Founded:

1991

Status:

PublicIndependent CompanyNASDAQMYGN

SIC Code:

2836 NAICS listing »

2834 NAICS listing »

Website:

Annual Revenue
Employees
Sector
Biotechnology
Headquarters

MYRIAD TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in Myriad's competitive set are Ambry Genetics, Quest Diagnostics, Gene by Gene, Bio-Techne, Acorda, Foundation Medicine, MolecularMD, 23andMe, Cardiff Oncology, Color. Together they have raised over 2.2B between their estimated 156.8K employees. Myriad has 2,600 employees and is ranked 3rd among it's top 10 competitors. The top 10 competitors average 3,723.

Ambry Genetics is perceived as one of Myriad's biggest rivals. Ambry Genetics's headquarters is in Aliso Viejo, California, and was founded in 1999. Ambry Genetics operates in the Biotechnology industry. Ambry Genetics generates 25% of Myriad's revenue.

Quest Diagnostics has been one of Myriad's top competitors. Quest Diagnostics is a Public company that was founded in 1967 in Secaucus, New Jersey. Quest Diagnostics operates in the Biotechnology industry. Compared to Myriad, Quest Diagnostics has 46,400 more employees.

Gene by Gene is Myriad's #3 rival. Gene by Gene was founded in Houston, Texas} in 2000. Gene by Gene is in the Biotechnology industry. Compared to Myriad, Gene by Gene generates $605.4M less revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Foundation Medicine a competitor of Myriad?

I don't know

Trending News for Myriad and Myriad's Competitors

May 4, 2021

The Business Journals: Greensboro/Winston-Salem/High Point

LabCorp acquires autoimmune testing business from Myriad Genetics

"We've always said that acquiring local laboratories or hospital laboratories or regional laboratorie... See more »

May 5, 2021

Ambry Genetics Blog

Dr. Chia-Ling Gau on Asian American Identity and the Future of Genomics

Dr. Chia-Ling Gau shares what being Asian American means to her, the future of genomics, and the impo... See more »

May 6, 2021

MarketScreener

Acorda Therapeutics : Provides Financial and Business Update for First Quarter 2021

(marketscreener.com) Acorda Therapeutics 2021 Q1 Earnings Call May 6, 2021 Forward Looking Statement ... See more »

Myriad Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$625.4M

Myriad's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 853.6M. Over the last four quarters, Myriad's revenue has decreased by 11.3%. Specifically, in Q1 2021's revenue was $173.1M; in Q2 2020, it was $93.2M; in Q1 2020, it was $164M; in Q4 2019, Myriad's revenue was $195.1M.

Myriad Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Counsyl, Inc.

May 2018

Source »
$375M
Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.
Assurex Health, Inc.

Aug 2016

Source »
$225M
AssureRx Health is a precision medicine company that specializes in pharmacogenomics for behavioral health and chronic pain.
Sividon Diagnostics

May 2016

Source »
$38.9M
Sividon Diagnostics develops and commercializes genomic-based diagnostic test for breast cancer treatment.
Crescendo Bioscience, Inc.

Feb 2014

Source »
$270M
Crescendo Bioscience develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases.

These are all the companies that Myriad has acquired. Myriad has acquired 4 companies and its latest acquisition was Counsyl, Inc. in May 2018. Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.

Myriad Funding History

Since Myriad was founded in 1991, it has participated in 1 round of funding. In total Myriad has raised $249.4K. Myriad's funding round was on Feb 2019 for a total of $249.4K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Feb 2019
$249.4K
-

Total Funding: $249.4K

Since Myriad was founded in 1991, it has participated in 1 round of funding. In total Myriad has raised $249.4K. Myriad's funding round was on Feb 2019 for a total of $249.4K

Myriad Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

RainDance is a provider of genetic analysis solutions for the early detection of cancer and infectious diseases.
$16.5M
Mar 02, 2014
Series E
Jan 01, 2017
RainDance is a provider of genetic analysis solutions for the early detection of cancer and infectious diseases.
$41.9M
Apr 11, 2013
Series E
Jan 01, 2017

These are all the companies that Myriad has invested in. Myriad has invested 4 companies and its latest investment was Counsyl, Inc. in May 2018. Counsyl is a provider of genetic testing and DNA screening services for men, women and children to aware about their genetic conditions.

Myriad News

May 4, 2021Seeking Alpha

Myriad Genetics gains as Q1 financials indicate a return to growth

See more »
May 3, 2021Markets Insider

Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives

Highlights:Revenue of $173.1 million increases 12% sequentiallyGAAP earnings per share of ($0.52), ad... See more »
May 3, 2021FinanzNachrichten

Myriad Genetics Targets To Be Profitable By Q4

WASHINGTON (dpa-AFX) - Myriad Genetics, Inc. (MYGN) said the company is focused on returning to long-... See more »
May 2, 2021Genomeweb

Myriad Genetics' Quarterly Revenues Increase 6 Percent

For the three months ended March 31, the firm reported total revenues of $173.1 million, beating the ... See more »
April 27, 2021MarketScreener

Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021

(marketscreener.com) SALT LAKE CITY, April 27, 2021 -- Myriad Genetics, Inc. , a leader in genetic te... See more »
April 27, 2021Genomeweb

Castle Biosciences Acquires Myriad Genetics' MyPath Melanoma Test, Lab for $32.5M

The sale, part of Myriad's planned strategic refocusing of its business, will allow Castle to bolster... See more »
March 29, 2021Markets Insider

Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders

SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in ... See more »

Myriad Blogs

June 9, 2020Myriad Genetics Blog

Myriad Corporate Statement

We are heartbroken over the systemic discrimination and racism that have persisted in this nation for... See more »
March 1, 2020Myriad Genetics Blog

3 Tips to Help Lower Your Risk of Colon Cancer

The post 3 Tips to Help Lower Your Risk of Colon Cancer appeared first on Myriad Genetics, Inc..... See more »
February 5, 2020Myriad Genetics Blog

Myriad Genetics 2020 Facts at a Glance

Myriad Genetics has been in business for almost 30 years and we are a global leader in precision medi... See more »
January 2, 2020Myriad Genetics Blog

When Gray Days Lead to "the Blues"

Fall slump. The winter blahs. Is it almost spring? Weather can have an impact on our daily mood and f... See more »
October 1, 2019Myriad Genetics Blog

3 Tips to Help You Prevent Breast Cancer

The post 3 Tips to Help You Prevent Breast Cancer appeared first on Myriad Genetics, Inc..... See more »
September 18, 2019Myriad Genetics Blog

The Importance of Hereditary Cancer Testing for Patients with Pancreatic Cancer

Pancreatic cancer is the third leading cause of death due to cancer.1 Approximately 56,500 people, or... See more »
July 11, 2019Myriad Genetics Blog

1 in 5 Minorities Struggle with Depression in the United States

July is Minority Mental Health Awareness Month. It is estimated that 1 in 5 minorities struggle with... See more »

Myriad Press Releases

March 24, 2021GlobalNewswire

Myriad Genetics Receives Additional Reimbursement for myChoice Diagnostic System in Japan

Comprehensive Test Helps Identify Women with Advanced Ovarian Cancer Who May Benefit from First-Line ... See more »
February 23, 2021GlobalNewswire

Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan

Highlights:... See more »
February 16, 2021GlobalNewswire

Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021

SALT LAKE CITY, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in g... See more »
January 19, 2021GlobalNewswire

Myriad Genetics Receives Reimbursement for BRACAnalysis Diagnostic System in Japan

Patients with Prostate or Pancreatic Cancer to Benefit from Treatment with Lynparza... See more »
January 18, 2021PR Newswire

Purcell Julie & Lefkowitz LLP Is Investigating Myriad Genetics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, Jan. 18, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedica... See more »
November 11, 2020StreetInsider

New Data Show Importance of Vectra Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid Arthritis

See more »
September 22, 2020EIN Presswire

Myriad Genetics and Sandstone Diagnostics Form Point-of-Care Blood Collection Partnership

Collaboration will enable doctor's office capillary blood draws, sample prep, and lab transport for a... See more »

Myriad Videos

June 18, 2020Myriad Genetics Youtube Channel

"Myriad Oncology Virtual Test Ordering" on YOUTUBE

See more »
May 13, 2020Myriad Genetics Youtube Channel

"Mental Health Month and GeneSight" on YOUTUBE

See more »
April 21, 2020Myriad Genetics Youtube Channel

"Myriad Women's Health Virtual Test Ordering" on YOUTUBE

See more »
March 25, 2020Myriad Genetics Youtube Channel

"Providing Testing Services Without Interruption" on YOUTUBE

See more »
March 18, 2020Myriad Genetics Youtube Channel

"Colon Cancer: Nicole Lambert" on YOUTUBE

See more »
February 26, 2020Myriad Genetics Youtube Channel

"Employee Spotlight: Brad" on YOUTUBE

See more »
February 19, 2020Myriad Genetics Youtube Channel

"Affordability: Genetic Testing for Hereditary Cancer" on YOUTUBE

See more »

Social Media

Myriad Headquarters

320 Wakara Way

Salt Lake City, Utah84108

800-469-7423

Driving Directions »

Trending Companies

Myriad Summary

ABOUT

Overview

Myriad is a personalized medicine company that discovers and commercializes molecular diagnostic tests and equipment for inherited diseases. Myriad was founded in 1991. Myriad's headquarters is located in Salt Lake City, Utah, USA 84108. It has raised...

CEO

Myriad's President & CEO, Paul J. Diaz, currently has an approval rating of 86%. Myriad's primary competitors are Ambry Genetics, Quest Diagnostics & Gene by Gene.

Website

myriad.com

Frequently Asked Questions about Myriad

  1. When was Myriad founded?

    Myriad was founded in 1991

  2. Who is Myriad's CEO?

    Myriad's CEO is Paul J. Diaz

  3. How much revenue does Myriad generate?

    Myriad generates $625.4M in revenue

  4. How much funding does Myriad have?

    Myriad has historically raised $249.4K in funding

  5. Where is Myriad's headquarters?

    Myriad's headquarters is in Salt Lake City Utah, USA

  1. How many employees does Myriad have?

    Myriad has 2,600 employees

  2. What sector does Myriad operate in?

    Myriad is in Biotechnology

  3. Who are Myriad's competitors?

    Myriad's top competitors are Ambry Genetics, Quest Diagnostics, Gene by Gene

  4. Who has Myriad invested in?

    Myriad's has invested in companies such as RainDance, RainDance
Stay up-to-date with the latest news on Myriad

© 2021 Owler, Inc.